Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07668427

The Impact of a Web-based Empowerment Program on Intolerance of Uncertainty and Maintenance Burden.

The aim of this study is to examine the relationship between uncertainty intolerance and caregiver burden in a web-based empowerment program based on uncertainty theory in disease, applied to caregivers of prostate cancer patients.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

About this study

This study was designed as a pre-test-post-test parallel-group, randomized controlled experimental design. The research will be conducted at the Radiation Oncology Clinic of Necmettin Erbakan University Faculty of Medicine Hospital, Republic of Turkey. Caregivers of prostate cancer patients will be randomly divided into two groups: experimental group (31) and control group (31). For the experimental group: A web-based reinforcement program based on uncertainty theory will be applied. For the control group: No application will be made to the caregivers. The primary outcome of this study is to determine the intolerance to uncertainty scores of caregivers of prostate cancer patients. The secondary outcome is to determine the caregiving burden of caregivers.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Over 18 years of age,
  • Able to speak Turkish,
  • Literate,
  • No hearing or vision problems,
  • No neurological and/or psychiatric disorders,
  • Physical and cognitive health levels suitable for answering the forms used in the study,
  • Having a patient diagnosed with prostate cancer,
  • Being the primary caregiver responsible for meeting the patient's care needs (home care, supervision, hospital check-ups, etc.) within the family,
  • Having a patient scheduled for hormone therapy and radiotherapy,
  • Not having undergone prostatectomy,
  • Having an electronic device such as a smartphone or computer with internet access, either themselves or a family member,
  • Caregivers of prostate cancer who volunteer to participate in the study will be included.

Exclusion criteria

  • Caregivers whose patients are receiving chemotherapy will be excluded.

Treatment and study plan

Web-Based Empowerment Program Based on Uncertainty Theory

Other

Web-Based Empowerment Program Based on Uncertainty Theory

Primary outcomes

  1. Intolerance of Uncertainty Scale

    Time frame: first week and fifteenth week

    The highest possible score on the scale is 60, and the lowest is 12. Higher scores indicate a high level of intolerance for uncertainty. Higher scores indicate greater intolerance for uncertainty.

Secondary outcomes

  1. Zarit Caregiver Burden Scale

    Time frame: first week and fifteenth week

    The scale can be scored from a minimum of 0 to a maximum of 88 points. A high score on the scale indicates a high caregiver burden.

Study contacts

Contact information is provided by the study sponsor or research team.

Kübra Nur KÖSE ALABAY

CONTACT

[email protected]

+905544319384

Sponsors and collaborators

Lead sponsor

Necmettin Erbakan University

Other

Registry information

Official study title

The Effect of a Web-Based Empowerment Program Based on the Theory of Illness Applied to Caregivers of Prostate Cancer Patients on Intolerance of Uncertainty and Caregiver Burden: A Randomized Controlled Trial

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Jun 25, 2026
Registry last updated
Jun 25, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.